1.Huanyu Xiang#,Jing Xiao#,Zilin Sun,Zongyi Liu,Junhao Zhang, Hongyan Xiang,Hong Ren,Peng Hu * , Mingli Peng * .(2023)The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels.Biomedicine & Pharmacotherapy.165:115051.（IF：7.5）
2.Zhiwei Chen#，Tianquan Huang#，Taiyu He#，Guanhua Zha，Qian Zhu， Gaoli Zhang，Dejuan Xiang，Min Chen，Hu Li，Ning Ling，Yinghua Lan， Xiaofeng Shi，Dazhi Zhang，Pan Xu，Qingbo Pan，Rui Song，Junxiong Cao，Yingzhi Zhang，Hongyan Xiang，Yali Feng，Ziqiao Yang，Biqiong Zhang，Wei Shen，Dachuan Cai*，Mingli Peng*，Peng Hu*，Hong Ren*.(2023)Humoral responses after primary and booster SARS‐CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study.J Med Virol.95(4):e28695.（IF：20.693）
3.Lei Yang#,Feng Xiang#,Dian Wang,Qiao Guo,Bing Deng,DePeng Jiang*, Hong Ren*.(2023)The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.42(4):503-512.(IF: 5.1)
4.Siliang Zhang#,Jiaoxia He#,Bin Tang,Qin Zhou,Yudong Hu,Yuan Yu, Jianwei Chen,Ling Zhong,Yi Liu,Chunmeng Li*,Hong Ren*,Xiaohui Liao*.(2023)Cellular and humoral Responses to recombinant and inactivated SARS-CoV-2 Vaccines in CKD patients.Journal of Clinical Medicine.12(3):1225.(IF:4.964)
5.Feng Xiang#,Boyu Long#,Jiaoxia He,Feifei Cheng,Sijing Zhang,Qing Liu,Zhiwei Chen,Hu Li,Min Chen,Mingli Peng,Wenwei Yin,Dongfang Liu*, Hong Ren*.(2023) Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines. Virology Journal. (IF: 5.9)
6.Taiyu He#,Ning Ling#,Gaoli Zhang#,Dejuan Xiang,Peng Hu,Mingli Peng, Dachuan Cai,Dazhi Zhang,Min Chen*,Hong Ren*.(2023)Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection. Immun Inflamm Dis.11(1):e759. (IF: 3.2)
7.Hu Li#,Dachuan Cai#,Depeng Jiang,Xingsheng Li,Xiaohui Liao, Dongfang Liu,Zuojin Liu,Peng Zhu,Guobing Yin,Jia Ming,Mingli Peng,Min Chen,Ning Ling,Yinghua Lan,Dazhi Zhang*,Peng Hu*,Hong Ren*.(2023)Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China. Journal of Medical Virology.95(1):e28434. (IF=20.693)
8.Yingzhi Zhou#,Zhiwei Chen#,Yi He#,Xiaorong Peng,Yunan Chang,Aoxue Tan,Hu Li,Dachuan Cai,Peng Hu,Min Chen,Mingli Peng*,Hongmei Xu*,Hong Ren* .(2023)Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection.Front Cell Infect Microbiol.13:1201101.(IF：6.073)
9.Ting Lu#,Zhiwei Chen#,Yu Cao#,Ling Ao#,Zisheng Li,Xiaoyi Gu,Xingqian Ren,Yixuan Wang,Gaoli Zhang,Dejuan Xiang,Min Chen,Dachuan Cai,Peng Hu,Dazhi Zhang*，Mingli Peng*，Xiaofeng Shi*,Hong Ren*.(2023)Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study.J Med Virol.95(4):e28730. (IF=20.693)
10.Qiao Tang#,Zhiwei Chen#,Hu Li,Li Zhang,Mingli Peng,Yi Zeng,Xiaoqing Liu,Zubi Liu*,Peng Hu*.(2023)Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis.Infect Dis Poverty.12(1):66.（IF=8.1）
11.Shen Wei#,Xiang Hongyan,Huang Tianquan,Tang Hui,Peng Mingli,Cai Dachuan,Hu Peng*,Ren Hong*.(2023) KMCP: accurate metagenomic profiling of both prokaryotic and viral populations by pseudo-mapping. Bioinformatics.39 (11).(IF: 5.8)
12.Yu PP#,Yang HC#,Qi XY,Bai YX,Zhang SQ,Gong JP,Ying M*,Hu P*. (2023)Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China. Lipids Health Dis. 21(1):148.（ IF: 4.5）
13.Zhang Q,Liu X,Pang X,Wang H,Du J,Ren H,Hu P*. (2023) Recovery of host adaptive immune function promoted the reduction of hepatitis B surface antigen in nucleoside analog-experienced chronic hepatitis B patients with low hepatitis B surface antigen levels. Cytokine.164:156140. (IF: 3.8)
14. Long B#,Tao H#,Tong S*,Wang X*,Yin W*.（2023）Short-term fasting attenuates lipopolysaccharide/D-galactosamine-induced acute liver failure through Sirt1-autophagy signaling in mice.MedComm .4(6):e412. （IF: 9.9）
15.Zhihua Ma#,Yi Zeng#,Ming Wang#,Wei Liu,Jiafeng Zhou,Chao Wu,Lin Hou,Bin Yin,Boqin Qiang,Pengcheng Shu*,Xiaozhong Peng*.（2023）N4BP1 mediates RAM domain-dependent notch signaling turnover during neocortical development. EMBO J. 42(22):e113383. (IF=11.4)
16. Qian Zhu#, Lu Wang#, Xiaoxiao Hu, Yingzhi Zhang, Tianquan Huang, Taiyu He, Zhiwei Chen, Gaoli Zhang, Mingli Peng, Min Chen, Dachuan Cai, Xiaofeng Shi* and Hong Ren*.（2023）Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis. Journal of Clinical and Translational Hepatology.（IF=3.6）
17.He T#, Luo N#, Kang J, Ling N, Zhang D*.（2023）Use of metagenomic next-generation sequencing for diagnosis of peritonitis in end-stage liver disease. Int J Med Sci.20(13):1698-1704（IF：3.6）
18.Huang LL，Luo FY，Huang WQ，Guo H，Liu Q，Zhang L，Jin AS，Sun H*. （2023）Augmenter of liver regeneration monoclonal antibody promotes apoptosis of hepatocellular carcinoma cells.J Clin Transl Hepatol.11（3）：605-613.（IF: 5.065）
19.Xiao J#,Xiang H#,Xiang H,Sun Z,Xu J,Ren H,Hu P*,Peng M*.（2023） GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.Eur J Pharmacol. 12:176113.(IF:5.0)
20.Xiang H#,Xiao J#,Sun Z,Liu Z,Zhang J,Xiang H,Ren H,Hu P*,Peng M*.(2023) The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels. Biomed Pharmacother.165:115051. (IF: 7.5)
21.Luo Y#,Chen Z#,Li Z,Luo A,Zeng Y,Chen M,Peng M,Ren H*,Hu P*. (2023) TDF Promotes Glycolysis and Mitochondrial Dysfunction to Accelerate Lactate Accumulation by Downregulating PGC1α in Mice. J Clin Transl Hepatol.11(4):998-1002. (IF: 3.6)
22.Li S, Tong J, Li H, Mao C, Shen W, Lei Y, Hu P*.(2023) L. pneumophila Infection Diagnosed by tNGS in a Lady with Lymphadenopathy. Infect Drug Resist. 16:4435-4442.(IF: 3.9)
23.Wang XH#, Peng BB#, Zhang L, Zhao J, Zhang L, Ren H, Hu P, Li H*, Zhong S*. (2023) Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study. Hepatol Int.17(5):1241-1250.(IF: 6.6)
24.Tongdong Shi,Zaoxiu Hu,Li Tian,Yanlong Yang*.(2023)Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.Respir Res.24(1):113.（IF：7.16）
25.Tongdong Shi#, Zaoxiu Hu#,Li Tian，Yanlong Yang*. (2023)Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer. Translational Oncology 34：101691.(IF：5.0)
26.Tian L,Tang S,Wang N,Deng H, Zhang Q and Shi T (2023). Hepatic and portal vein Doppler ultrasounds in assessing liver inflammation and fibrosis in chronic HBV infection with a normal ALT level. Front Med (Lausanne).10:1178944.(IF：3.9)
27.ZhanZ, Zeng W, Liu J, Zhang L, Cao Y, Li P, Ran H, Wang Z*. Engineered Biomimetic Copper Sulfide Nanozyme Mediates "Don't Eat Me" Signaling for Photothermal and Chemodynamic Precision Therapies of Breast Cancer. ACS Appl Mater Interfaces.15(20):24071-24083.(IF:10.3)
28.Peng Zhou#,Wen-Yi Chang#,De-Ao Gong#,Lu-Yi Huang,Rui Liu,Yi Liu,Jie Xia,Kai Wang*,Ni Tang*,Ai-Long Huang*.(2023)O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.Oncogene.
42(10):725-736（IF：8）
29.Huating Luo#,Qiujie Wang#,Fan Yang#,Rui Liu#,Qingzhu Gao#,Bin Cheng,Xue Lin,Luyi Huang,Chang Chen,Jin Xiang,Kai Wang*,Bo Qin*,Ni Tang*.(2023)Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.JCI Insight.8(23):e164968.（IF：8）
30.De-Ao Gong#,Peng Zhou#,Wen-Yi Chang#,Jia-Yao Yang,Yan-Lai Zhang,Ai-Long Huang,Ni Tang*,Kai Wang*.（2023）SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.Biochim Biophys Acta Mol Cell Res.1871(2):119642（IF：5.1）
31.Xiaoqun Shan#,Rong Jiang#,Dongmei Gou,Jin Xiang,Peng Zhou, Jie Xia,Kai Wang,Ailong Huang,Ni Tang*,Luyi Huang*.（2023）Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.FEBS J.290(18):4543-4561.（IF：5.6）
32.Shenglan Mao,Xuefei Cai,Siqiang Niu,Jie Wei，Ning Jiang,Haijun Deng,Wen Wang,Jing Zhang,Shimei Shen,Yuanyan Ma,Xiaoli Wu,Qiling Peng*,Ailong Huang*,Deqiang Wang*.（2023）TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity.J Med Virol.95(4):e28719.（IF：20.693）
33.Yun Li#, Tao Wang#, Qiumin Liao#, Xiaoting Luo, Xing Wang, Shu Zeng , Mengyue You, Yaxi Chen, Xiong Z Ruan.（2023）Loss of Splicing Factor SRSF3 Impairs Lipophagy Through Ubiquitination and Degradation of Syntaxin17 in Hepatocytes.J Lipid Res.64(3):100342.（IF：6.5）
34.Guo Zheng#,Yu Su#,Li Wei#,Yingcheng Yao,Yizhe Wang,Xiaoting Luo, Xing Wang,Xiong Z Ruan,Danyang Li*, Yaxi Chen*.（2023）SCAP contributes to embryonic angiogenesis by negatively regulating KISS-1 expression in mice.Cell Death Dis.14(4):249.（IF：9）
35.Mengyue Chen#,Yang Zhang#,Shu Zeng#,Danyang Li,Mengyue You, Mingyang Zhang,Zhenyu Wang,Li Wei,Yaxi Chen*,Xiong Z Ruan*.（2023）CD36 regulates diurnal glucose metabolism and hepatic clock to maintain glucose homeostasis in mice.iScience.26(4):106524.（IF：6.107）
36.Yanping Li#,Jingyuan Xu#,Weiting Chen#,Xingxing Wang#,Zhibo Zhao, Yuqi Li,Linkun Zhang,Junkui Jiao,Qin Yang,Qiuying Ding,Ping Yang,Li Wei, Yao Chen*,Yaxi Chen*,Xiong Z Ruan*,Lei Zhao*.（2023）Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury.Autophagy.19(9):2504-2519.（IF：13.3）
37.Qian Ye#, Yi Liu#, Guiji Zhang#, Haijun Deng#, Xiaojun Wang#, Lin Tuo#, Chang Chen, Xuanming Pan, Kang Wu, Jiangao Fan, Qin Pan, Kai Wang*, Ailong Huang*, Ni Tang*.（2023）Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice.Nat Commun.14(1):1402.（IF：16.6）
38.Dongmei Gou#, Rui Liu#, Xiaoqun Shan#, Haijun Deng#, Chang Chen#, Jin Xiang, Yi Liu, Qingzhu Gao, Zhi Li, Ailong Huang*, Kai Wang*, Ni Tang* .（2023）Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.J Clin Invest.133(13).（IF：15.9）
39.Peng Zhou#, Wen-Yi Chang#, De-Ao Gong#, Jie Xia#, Wei Chen, Lu-Yi Huang, Rui Liu, Yi Liu, Chang Chen, Kai Wang*, Ni Tang*, Ai-Long Huang*.（2023）High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.Cell Metab.35(11):1961-1975.（IF：29）
40.Kang Wu#, Yi Liu#, Jie Xia#, Jiale Liu#, Kai Wang, Huijun Liang, Fengli Xu, Dina Liu, Dan Nie, Xin Tang,Ailong Huang*,Chang Chen*,Ni Tang*.（2023）Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid.Adv Sci (Weinh).13:e2304408.（IF：15.1）
41.Yu Sha #, Mingang Pan #, Yunmeng Chen #, Liangjun Qiao, Hengyu Zhou , Dina Liu, Wenlu Zhang, Kai Wang, Luyi Huang, Ni Tang, Jianguo Qiu*, Ailong Huang*, Jie Xia*.（2023）PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatocellular carcinoma.Cell Death Discov.9(1):176.（IF：7.113）
42.Mingang Pan#, Yu Sha#, Jianguo Qiu, Yunmeng Chen, Lele Liu, Muyu Luo, Ailong Huang*, Jie Xia*.（2023）RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma.Int J Mol Sci.24(9):7905.（IF：6.208）
43.Peng Zhou#, Wen-Yi Chang#, De-Ao Gong#, Jie Xia#, Wei Chen, Lu-Yi Huang, Rui Liu, Yi Liu, Chang Chen, Kai Wang*, Ni Tang*, Ai-Long Huang*.（2023）High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.Cell Metab.35(11):1961-1975.（IF：29）
44.Jie-Li Hu#，Ai-Long Huang*. (2023)Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review.Microorganisms.11(3):600.（IF:4.9）
45.Xiaosong Li#,Pai Peng#,Haijun Deng#,Qian Yang,Shi Chen,Benhua Li,Miao He,Aishun Jin,Zhu Yang,Ni Tang*,Ailong Huang* (2023)Real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19.Signal Transduct Target Ther.8(1):403.（IF：39.3）
46.Dongmei Gou#,Rui Liu#,Xiaoqun Shan#,Haijun Deng#,Chang Chen,Jin Xiang,Yi Liu,Qingzhu Gao,Zhi Li,Ailong Huang*,Kai Wang*,Ni Tang*.(2023)Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.133(13):e161713.（IF：15.9）
47.Yang Yang#,Yu Yan#,Jiaxin Yin#,Ni Tang#,Kai Wang#,Luyi Huang,Jie Hu,Zhongqi Feng,Qingzhu Gao,Ailong Huang*.(2023)O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner.Signal Transduct Target Ther.8(1):63.（IF：39.3）